4.8 Letter

Third BNT162b2 Vaccination Neutralization of SARS-CoV-2 Omicron Infection

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Infectious Diseases

Infections, hospitalisations, and deaths averted via a nationwide vaccination campaign using the Pfizer-BioNTech BNT162b2 mRNA COVID-19 vaccine in Israel: a retrospective surveillance study

Eric J. Haas et al.

Summary: The nationwide vaccination campaign in Israel has successfully prevented a large number of SARS-CoV-2 infections, hospitalizations, and deaths, especially among individuals aged 65 years and older. The full vaccination of the population has played a significant role in controlling the pandemic.

LANCET INFECTIOUS DISEASES (2022)

Article Medicine, General & Internal

Protection of BNT162b2 Vaccine Booster against Covid-19 in Israel

Yinon M. Bar-On et al.

Summary: After receiving a third dose of the BNT162b2 mRNA vaccine, Israeli residents aged 60 and above who had previously received two doses of the vaccine saw significantly lower rates of confirmed Covid-19 infection and severe illness compared to those who did not receive a booster shot, indicating the effectiveness of the booster dose in reducing infection and severe illness.

NEW ENGLAND JOURNAL OF MEDICINE (2021)